The Dangers of Race-Based Medicine
An analysis of new drug therapies specifically targeted towards African American populations with hypertension.
I. Introduction to Contemporary Race-Based Therapeutics
On November 11th, 2004, NitroMed, a Massachusetts based pharmaceutical company published a study on the effects of a new drug called BiDil in treating heart failure among African Americans in the New England Journal of Medicine (Taylor 2049). Since announcing the study, NitroMed’s research has sparked controversy surrounding the ethical implications and scientific evidence of race-based medicine. This study marks a breakthrough in race-based drug treatments as the first pharmaceutical ever researched, endorsed and targeted for a single ethnic group (Pollack 1). The racially-specific pharmaceutical initiative is a product of tremendous government funding allotted by the Clinton administration to the Human Genome Project at the turn of the millennium. Since then, much medical research has focused on understanding the human genome in search of genetic explanations for health problems while funding and interest have decreased in social-related health research and medical programs for poor and underserved populations (Braun 162).
NitroMed’s study marks a growing movement that has begun to cite genetic makeup, specifically race-related genetic makeup, rather than environmental or other confounding factors as the source of disease. This shift in presumed cause of health-related problems raises many troubling implications. With race-based therapeutics comes the assumption that there are biological differences between races. The dangers of such implications are vast, the most pressing problem being the ambiguity of race, particularly with regard to genetic composition. Considerable studies have demonstrated the lack of genotypic correlations among members of a given race. Similarly, socioeconomic and other confounding variables have a profound impact on health and thus must be considered in the discussion of race-based therapeutics and research. This tension between social and biological conceptions of race is now at the forefront of discussion among scientific scholars seeking explanations for the relationship of disease and ethnicity (Foster 844).
The ultimate goal of pharmacogenomics, as stated by Henig, “would be for everyone’s genome to be analyzed indi...
... middle of paper ...
...atients.” New York Times
20 July 2004: 1.
“Racial Diversity in Drug Trials Can Produce Breakthroughs.” USA Today 15 Nov
2004: 14a.
“Racing to Conclusions.” Scientific American 289:9 (2003): 1-2.
Rosenberg, Ronald. “Firm to test heart drug for blacks.” Boston Globe 10 March 2001:
1-2.
Tate, Sarah K and David B. Goldstein. “Will Tomorrow’s medicines work for
everyone?” Nature Genetics 36: 11 (2004): S34-42
Taylor, Anne L., et al. “Combination of Isosorbide Dinitrate and Hydralazine in Blacks
with Heart Failure.” New England Journal of Medicine 351:20 (2004): 2049-2057
Tishkoff, Sarah A, and Kenneth K. Kidd. “Implications of biogeography of human
populations for ‘race’ and medicine.” Nature Genetics 36:11 (2004): S21-27.
Wade, Nicholas. “Articles Highlight Different Views on Genetic Basis of Race.” New
York Times 27 October 2004: 13.
Wade, Nicholas. “Raced-Based Medicine Continued…” New York Times 14 Nov 2004:
12.
Yancy, Clyde W. “Does Race Matter in Heart Failure?” American Heart Journal 146
(2003): 203-206.
Yancy, Clyde W. “Heart Failure in African Americans: A Cardiovascular Enigma.”
Journal of Cardiac Failure 6:3 (2000): 183-186.
Healthcare systems are microcosms of the larger society in which they exist. Where there is structural violence or cultural violence in the larger society, so will there be evidence of systematic inequities in the institutions of these societies. The healthcare system in Australia is one example—from a plethora of similarly situated healthcare systems—in which the color of a patient’s skin or the race of his parents may determine the quality of medical received. Life expectancy and infant mortality rates are vastly different for non-Aboriginal, Aboriginal, and Torres Strait Islanders residing in Australia. The life expectancy of Aboriginal men is 21 years shorter than for non-Aboriginal men in Australia. For women, the difference is 19 years. The infant mortality rate of Aboriginal and Torres Strait Islander male infants is 6.8% and the infant mortality rate for female infants is 6.7%. For non-Aboriginal infants, the infant mortality rates are 1% for male infants and 0.8% for female infants. Further, the Aboriginal population is subject to a wide-range of diseases that do not exhibit comparatively high incidence rates in non-Aboriginal Australians.
Any notable person with medical expertise will testify that racial identities bear no scientific weight and one’s race is only as significant as the person--or culture the said person is submerged in--makes it out to be. When dissected sociologically, “race prejudice [is] an irrational manifestation of individual pathologies” (Racial Fault Lines, 17)... “[that] represent attempts by one group of people to secure for themselves a privileged position in the social structure at the expense of stigmatized and subordinated social groups,” (Racial Fault Lines, 18). And, while the privileged groups’ “superiority” and other groups’ “inferiority” is arbitrary and holds no ethical legitimacy, the damage caused to the “inferior” groups is undeniable and enormously detrimental. Tomás Almaguer, in his insightful book, Racial Fault Lines: The Historical Origins of White Supremacy in California, explores the various ways in which the Mexican, Native American, and Asian populations in the late nineteenth century
Large disparities exist between minorities and the rest of Americans in major areas of health. Even though the overall health of the nation is improving, minorities suffer from certain diseases up to five times more than the rest of the nation. President Clinton has committed the nation to eliminating the disparities in six areas of health by the Year 2010, and the Department of Health and Human Services (HHS) will be jumping in on this huge battle. The six areas are: Infant Mortality, Cancer Screening and Management, Cardiovascular Disease, Diabetes, HIV Infection and AIDS, and Child and Adult Immunizations.
Does racism still exist today? Although many believe it was a problem in the past, it still exists today. Many People are still not aware that it still exists in our workforces, especially in medical field. Although racism in medicine can be very offense, it can sometimes be beneficial and help reveal differences in diseases based on genetic make up. These differences can be taken in the wrong manner and can lead to social problems especially if these distinctions are thought of as ethnic differences. In Gregg M. Bloche’s article. “Race, Money and Medicine”, he states that we should erase racial categories from medicine but only use them if they are beneficial for the patient’s health. Peter Clark, author of “Prejudice and the Medical Profession: A Five Year Update”, explains that racial categories should be understood because understand these different can be beneficial. Lynne D. Richardson and Marlaina Norris, authors of “Access to Health and Health Care: How Race and Ethnicity Matter”, also believe that these differences can be beneficial but want to improve the health are because they know a majority of minorities do not receive proper health care and treatment. Rebecca Skloot, author of “The Immortal Life of Henrietta Lacks”, pays attention to the fact that her character, Henrietta Lacks, was not given the proper treatment and care she should have. Although Henrietta’s cells were beneficial to cancer research , she never once gave consent to the doctor’s to distribute her cells. She was taken advantage of because of her race and low income. Minorities’ opinions and beliefs should be taken into perspective because they often feel neglected which causes a sense of “distrust”. There has been a vast history of racism in the ...
The contributing factor is lack of knowledge and family medical screening. Understanding the history of your genetic line specific to your race and ethnicity may be helpful in preventing heart disease later on in adulthood.... ... middle of paper ... ... Current studies of note have focused primarily on middle-class and/or suburban populations.
Studies have analyzed how African Americans deal with an enormous amount of disease, injury, death, and disability compared to other ethnic group, and whites, Utilization of health services by African Americans is less frequent than other ethnic groups in the country. This non utilization of services contributes to health disparities amongst African Americans in the United States. Current and past studies have shown that because of discrimination, medical mistrust, racial/ethnic background, and poor communication African Americans tend to not seek medical care unless they are in dire need or forced to seek professional care. African Americans would rather self –medicate than to trust a doctor who might show some type of discriminatory
...ular dystrophy, but less than $100,000 for SCA. National Institutes of Health grants for many less common hereditary illnesses exceed those for SCA.” (Gary A. Gibson, “Sickle cell disease: Still here and still causing Pain’) “If these conditions affected the white mainstream population rather than ethnic minority communities, maybe they wouldn’t be so badly overlooked.” (Sarah calkin, “Race ‘a factor” in variability of sickle cell services”) In these cases Race remind a big part when it’s affecting African American it’s a slow process on health care and researchers. If sickle cell was affecting more whites or wasn’t inherited the most by African American would it be a big deal as Cancer or HIV. Questions remind why cant sickle cell disease get much attention or funding for high organizations and researchers where is the social justice American suppose to have done.
In the past, races were identified by the imposition of discrete boundaries upon continuous and often discordant biological variation. The concept of race is therefore a historical construct and not one that provides either valid classification or an explanatory process. Popular everyday awareness of race is transmitted from generation to generation through cultural learning. Attributing race to an individual or a population amounts to applying a social and cultural label that lacks scientific consensus and supporting data. While anthropologists continue to study how and why humans vary biologically, it is apparent that human populations differ from one another much less than do populations in other species because we use our cultural, rather than our physical differences to aid us in adapting to various environments.
According to the institute of Medicine (IOM), racism is a problem in the health care system, that is, the difference between the quality of health care received by minorities and non-minorities is due to racism. IOM is a nonprofit organization that advises the federal government and the public on science policy. It released a report that on average, minorities receive a lower quality of care, even when factors such as income and type of health insurance are accounted for. The report by IOM states that racial stereotypes and prejudice are the cause of the health care disparities. The article by IOM points ...
Race-based medicine is not meant to divide people, but rather to give better medical help to people of a certain demographic. Race-based medicine is created based on knowledge of predispositions of any given race. For example, it is a fact that heart disease is the leading cause of death for racial groups including African-Americans, Hispanics, and whites in the United States. When medical experts have this knowledge, the process of making diagnoses is
Williams, D. R., & Jackson, P. (2014, April 1). Health Affairs. Social Sources Of Racial Disparities In Health. Retrieved April 29, 2014, from http://content.healthaffairs.org/content/24/2/325.short
Racial disparity in drug related convictions has been a wide spread problem in the United States since the War on Drugs in the early 1980s. It was prevalent before that time, but minorities became the target of drug related crimes in startling numbers at this time. There are several hypotheses for this alarming situation, but the bottom line remains that racism is the leading cause of racial disparity in drug related convictions. Minorities from inner cities, with low-incomes and socioeconomic statuses who get caught in a downward spiral, are the easiest targets for the government to point the finger at for drug problems in the United States. The statistics will show that while more White people use illicit drugs in the United States, more African Americans and other minorities will be convicted, and more harshly than their White counterparts, for the same crimes.
Pharmacogenomics is the study of variation in human genomes and how they are affected by a response to medications, due to heredity, that would be tailor-made to adapt to a person or population genetic make up to lessen drug-causing morbidity. Pharmacogenetics, which is an older term, was constructed from the words pharmacology and genetics, which now indicates the intersections of pharmaceuticals and genetics. The vision of pharmacogenomics is to offer safer and more effective drugs, where more people and populations use drug therapies which will increase the influence of drug-development clinical trials and products used in clinical practice. Patient’s selection must be evidence based in the testing of pharmacogenomics in order to avoid genetic profiling, discrimination, stigmatization or distribution injustice. The pharmacogenomics testing supplies information that could assist with the decision of treatment options for patients.
Seeking to position lower socioeconomic status above racial/ethnic biases or vice versa is irresponsible to the goal of eliminating healthcare delivery differences at large. Both these are realities of a group of people who are not receiving the same level of care from the healthcare professionals although they exist within one of the most resource rich countries in the world, the United States. According to House & Williams (2000), “racism restricts and truncates socioeconomic attainment” (page, 106). This alone will hinder good health and spur on disparities as racism reduces the level of education and income as well as the prospect of better jobs. Blacksher (2008) cites the nation’s institutionalized racism as one of the leading factors
Today’s society protects against discrimination through laws, which have been passed to protect minorities. The persons in a minority can be defined as “a group having little power or representation relative to other groups within a society” (The Free Dictionary). It is not ethical for any person to discriminate based on race or ethnicity in a medical situation, whether it takes place in the private settings of someone’s home or in a public hospital. Racial discrimination, in a medical setting, is not ethical on the grounds of legal statues, moral teachings, and social standings.